Praveen Tyle - Net Worth and Insider Trading

Praveen Tyle Net Worth

The estimated net worth of Praveen Tyle is at least $16,346 dollars as of 2024-12-01. Praveen Tyle is the Director of Kiora Pharmaceuticals Inc and owns about 5,014 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $16,346. Details can be seen in Praveen Tyle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Praveen Tyle has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Praveen Tyle

To

Praveen Tyle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Praveen Tyle owns 4 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , GI Dynamics Inc (GIDYL) , and Kiora Pharmaceuticals Inc (KPRX) among others .

Click here to see the complete history of Praveen Tyle’s form 4 insider trades.

Insider Ownership Summary of Praveen Tyle

Ticker Comapny Transaction Date Type of Owner
LXRX Lexicon Pharmaceuticals Inc 2016-05-16 EVP & R&D
GIDYL GI Dynamics Inc 2020-02-28 director
KPRX Kiora Pharmaceuticals Inc 2024-08-19 director
LIMIT LIMIT 2021-07-22 director

Praveen Tyle Latest Holdings Summary

Praveen Tyle currently owns a total of 1 stock. Praveen Tyle owns 5,014 shares of Kiora Pharmaceuticals Inc (KPRX) as of August 19, 2024, with a value of $16,346.

Latest Holdings of Praveen Tyle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KPRX Kiora Pharmaceuticals Inc 2024-08-19 5,014 3.26 16,346

Holding Weightings of Praveen Tyle


Praveen Tyle Form 4 Trading Tracker

According to the SEC Form 4 filings, Praveen Tyle has made a total of 1 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kiora Pharmaceuticals Inc is the acquisition of 5,000 shares on August 19, 2024, which cost Praveen Tyle around $19,800.

Insider Trading History of Praveen Tyle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Praveen Tyle Trading Performance

GuruFocus tracks the stock performance after each of Praveen Tyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Praveen Tyle is -20.05%. GuruFocus also compares Praveen Tyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Praveen Tyle within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Praveen Tyle's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Praveen Tyle

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.85 LIMIT LIMIT LIMIT LIMIT LIMIT

Praveen Tyle Ownership Network

Ownership Network List of Praveen Tyle

No Data

Ownership Network Relation of Praveen Tyle

Insider Network Chart

Praveen Tyle Owned Company Details

What does Lexicon Pharmaceuticals Inc do?

Who are the key executives at Lexicon Pharmaceuticals Inc?

Praveen Tyle is the EVP & R&D of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .

Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary

Over the past 18 months, Praveen Tyle made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .

In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.

Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexicon Pharmaceuticals Inc Insider Transactions

No Available Data

Praveen Tyle Mailing Address

Above is the net worth, insider trading, and ownership report for Praveen Tyle. You might contact Praveen Tyle via mailing address: One Bausch & Lomb Place, Rochester Ny 14604.

Discussions on Praveen Tyle

No discussions yet.